Fossom LH - Search Results

1

NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P. Popik P, et al. Among authors: fossom lh. J Pharmacol Exp Ther. 1995 Nov;275(2):753-60. J Pharmacol Exp Ther. 1995. PMID: 7473163

2

Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.

Fossom LH, Basile AS, Skolnick P. Fossom LH, et al. Mol Pharmacol. 1995 Dec;48(6):981-7. Mol Pharmacol. 1995. PMID: 8848014

3

Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs.

Bovetto S, Boyer P, Skolnick P, Fossom LH. Bovetto S, et al. Among authors: fossom lh. J Pharmacol Exp Ther. 1997 Dec;283(3):1503-8. J Pharmacol Exp Ther. 1997. PMID: 9400027

4

Sensitization and desensitization of the NMDA receptor complex. Implications for therapy.

Fossom LH, Skolnick P. Fossom LH, et al. Ann N Y Acad Sci. 1995 Sep 15;765:320-1. doi: 10.1111/j.1749-6632.1995.tb16601.x. Ann N Y Acad Sci. 1995. PMID: 7486630 No abstract available.

5

Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site.

Zhou LM, Szendrei GI, Fossom LH, Maccecchini ML, Skolnick P, Otvos L Jr. Zhou LM, et al. Among authors: fossom lh. J Neurochem. 1996 Feb;66(2):620-8. doi: 10.1046/j.1471-4159.1996.66020620.x. J Neurochem. 1996. PMID: 8592132

6

Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias.

Fossom LH, Skolnick P. Fossom LH, et al. J Neural Transm Suppl. 1997;49:235-44. doi: 10.1007/978-3-7091-6844-8_24. J Neural Transm Suppl. 1997. PMID: 9266432 Review.

7

Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.

Viu E, Zapata A, Capdevila JL, Fossom LH, Skolnick P, Trullas R. Viu E, et al. Among authors: fossom lh. J Pharmacol Exp Ther. 1998 May;285(2):527-32. J Pharmacol Exp Ther. 1998. PMID: 9580593

8

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

Boyer PA, Skolnick P, Fossom LH. Boyer PA, et al. Among authors: fossom lh. J Mol Neurosci. 1998 Jun;10(3):219-33. doi: 10.1007/BF02761776. J Mol Neurosci. 1998. PMID: 9770644

9

Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons.

Lin Y, Fossom LH, Skolnick P, Long JB. Lin Y, et al. Among authors: fossom lh. Eur J Pharmacol. 1998 Sep 4;356(2-3):255-60. doi: 10.1016/s0014-2999(98)00515-9. Eur J Pharmacol. 1998. PMID: 9774257

10

Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.

Nahum-Levy R, Fossom LH, Skolnick P, Benveniste M. Nahum-Levy R, et al. Among authors: fossom lh. Mol Pharmacol. 1999 Dec;56(6):1207-18. doi: 10.1124/mol.56.6.1207. Mol Pharmacol. 1999. PMID: 10570048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters